葡萄糖减轻DSS诱导的大肠炎,并与高结肠中链脂肪酸有关:一个综合的多omics分析
Geunsoo Kim1,2, Kaiwei Chen2, Zhiyuan Xing3
1Department of Infectious Diseases, Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
NPJ science of food
|November 18, 2025
概括
益生菌葡萄糖 (STA) 通过增加结肠中有益的中链脂肪酸 (MCFA) 来缓解实验性结肠炎. 这些MCFA可能会调解STA的保护作用,影响肠道微生物群和宿主基因表达.
科学领域:
- 胃肠病学 胃肠病学
- 微生物组研究 微生物组研究
- 代谢学 代谢学 代谢学
背景情况:
- 性结肠炎 (UC) 是一种慢性炎症性肠病.
- UC涉及肠道炎症,免疫问题和微生物失衡.
研究的目的:
- 为了研究益生菌粘菌酶 (STA) 对实验性结肠炎的影响.
- 探索STA治疗潜力的基础分子机制.
主要方法:
- 使用硫酸德克斯 (DSS) 的大肠炎小鼠模型.
- 采用综合的多omics方法:代谢学,转录学和16S rRNA测序.
- 分析了结肠代谢物,基因表达和肠道微生物群组成的变化.
主要成果:
- 葡萄糖 (STA) 补充剂减少了结肠炎的严重程度.
- STA增加了结肠中链脂肪酸 (MCFA),例如azelaic酸.
- 调节脂肪酸代谢基因和PPAR信号通路.
- 恢复了微生物多样性,并丰富了像Roseburia这样的有益细菌.
结论:
- 结肠MCFA是STA在实验性结肠炎中的保护作用的潜在调解者.
- STA影响宿主脂质代谢和肠道微生物组成.
- 研究结果表明,MCFA,微生物群和UC之间存在联系.
更多相关视频
相关概念视频
Inflammatory Bowel Disease II: Ulcerative Colitis
57
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
57
Inflammatory Bowel Disease III: Crohn's Disease
69
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69


